Achelios is developing A BEST-IN-CLASS TOPICAL TREATMENT FOR CHRONIC PAIN
It is estimated that about one in five or about 1.5 billion people, globally, suffer from chronic pain (CP).
- Pain is the #1 cause of prolonged disability.
- Pain affects more people than diabetes, heart disease, and cancer combined.
- Annual costs for chronic pain is over $600B annually in the U.S. and over 441B Euros in the European Union.
Chronic pain affects approximately 100 million Americans at one time or another. One in four people face pain on a daily basis. Of this, 33% is due to back pain, 30% to joint arthritis, and the rest to other conditions such as accidents, spine, neurological, and neuropathic pain.
In the US, the primary analgesics employed for treating chronic pain are opiates and oral nonsteroidal anti-inflammatory drugs (NSAIDS).
Both classes of drugs can produce severe side effects. NSAIDS can cause gastric ulceration and renal damage; opioids can cause nausea, constipation, confusion, and dependency problems.
100 Million Adults Suffer from Chronic Pain in the United States
-
1/2
Suffer Daily Pain
-
1/3
Suffer Mild Pain
-
1/3
Suffer Moderate Pain
-
1/3
Suffer Severe Pain
